SS-31, known clinically as elamipretide, is a mitochondria-targeted tetrapeptide that binds to cardiolipin on the inner membrane of the mitochondria, the structures that generate most of your cells' energy. Researchers have studied it for its potential to stabilize mitochondrial structure, support ATP production, and reduce oxidative stress in tissues with high energy demand. At Menscape Clinic in Bangkok, SS-31 is discussed within an anti-aging and vitality consultation as a research-stage peptide that may be considered, off-label and under medical supervision, for men interested in cellular-energy support. It is not a proven anti-aging treatment, and human evidence outside of specific rare diseases remains limited.
/)
Medically reviewed by Dr. Tuksaorn Suriyakan (Ping), Anti-Aging & Regenerative Medicine Physician
8 years of experience
Our solutions for Anti-Aging & Vitality
Indications evaluated in research, listed in order of current evidence weight. Suitability is determined case-by-case.
SS-31 is a four-amino-acid (tetrapeptide) compound developed clinically as elamipretide by Stealth BioTherapeutics, and previously known by the codes MTP-131 and Bendavia. Unlike most peptides, it is engineered to concentrate inside the mitochondria, where it binds to cardiolipin, a phospholipid found only on the inner mitochondrial membrane. Cardiolipin helps hold the mitochondria's folded internal structure together and supports the protein complexes that turn nutrients into ATP, the cell's main energy currency. SS-31 has been studied for its potential to keep this machinery stable when mitochondria are under stress. It is one of the most clinically investigated mitochondria-targeted peptides, having been tested in human trials for several conditions, though it remains research-stage for the anti-aging and vitality uses men typically ask about.
/)
The proposed mechanism centers on cardiolipin. By binding reversibly to this phospholipid, SS-31 is studied for stabilizing the cristae (the inner folds of the mitochondria), helping the electron transport chain assemble into efficient supercomplexes, and reducing the leak of reactive oxygen species that can damage cells. In laboratory and animal models this has been associated with improved energy output and less oxidative stress. It is important to be clear that much of this mechanistic detail comes from preclinical research, and that demonstrating a measurable benefit in healthy adults is a separate question that current human evidence does not settle.
/)
Within a vitality consultation at Menscape Clinic in Bangkok, SS-31 is sometimes discussed for men interested in cellular-energy and oxidative-stress support, often alongside peptides such as MOTS-c that also act on mitochondrial pathways. It is not appropriate for everyone. A physician will review your medical history, current medications, and goals, and will be candid that this is an experimental option with limited human data for general wellness, not a treatment for any diagnosed disease unless you have one for which it is specifically indicated. Men seeking a proven, approved therapy may be better served by other options the clinic offers.
/)
When SS-31 is considered appropriate, Menscape Clinic approaches it as a research-stage peptide prescribed off-label and, where compounded, sourced through a licensed pharmacy partner under medical supervision. It is typically administered by subcutaneous injection. Any protocol begins with a consultation and baseline assessment, includes clear discussion of the limited evidence and potential risks, and is monitored over time with follow-up. We do not promise specific outcomes, and we will not recommend SS-31 if a physician judges it unsuitable for you.
/)
Every SS-31 (Elamipretide) protocol starts with a full medical consultation and history review.
Prescriptions are filled by a licensed compounding pharmacy partner, not over-the-counter.
Follow-up consultations every four to six weeks to assess response and safety.
We frame SS-31 (Elamipretide) as a research-stage option and prescribe only when clinically appropriate.
In September 2025 the FDA granted accelerated approval to elamipretide, under the brand name Forzinity, but only for Barth syndrome, an ultra-rare inherited mitochondrial disease, to improve muscle strength in patients weighing at least 30 kg. It is not FDA approved for anti-aging, general vitality, athletic performance, or healthy-adult mitochondrial support. Used for those purposes it is off-label and, where compounded, prepared by a licensed pharmacy partner under medical supervision. Regulatory status differs by country, and a physician will explain what applies to you.
SS-31 cannot be called proven safe for general or long-term wellness use, because the human safety data outside specific disease trials is limited. In the trials that have been run, the most commonly reported issue was injection-site reactions. Like any peptide it carries risks, and individual responses vary. At Menscape Clinic it is only considered after a medical review, and you should disclose all medications and health conditions before starting.
The evidence is mixed and mostly early. There is solid preclinical (cell and animal) research on its cardiolipin mechanism, and it has been tested in multiple human trials. Its narrow FDA approval is based on a small crossover study in Barth syndrome. Several larger trials in conditions such as heart failure and mitochondrial myopathy did not meet their main endpoints, so claims about broad anti-aging benefit are not established.
Both are studied for mitochondrial function, which is why they are sometimes discussed together. SS-31 works at the inner mitochondrial membrane by binding cardiolipin to stabilize structure and energy production. MOTS-c is a mitochondrial-derived peptide studied more for metabolic signaling and exercise-related pathways. They act through different mechanisms, and a physician would decide whether either is appropriate.
In clinical research and in approved use, elamipretide is given by subcutaneous injection rather than as a tablet, because peptides are broken down in the digestive tract. If SS-31 is considered appropriate for you at Menscape Clinic, dosing and administration are determined by the physician and reviewed at follow-up. We do not publish a fixed protocol because it depends on the individual assessment.
No. SS-31 is researched for its effects on mitochondrial function, but no peptide can reverse aging, and we make no guarantee of increased energy or any other outcome. It should be viewed as an experimental option with limited human evidence for vitality use, considered only as part of a broader, medically supervised plan and an honest conversation about what is and is not known.
/)
Dr. Tuksaorn (Dr. Ping) is an anti-aging and regenerative medicine physician with over 8 years of experience, focused on evidence-based wellness and personalized health programs that combine modern medical science with individualized care.
/)
/)
/)
/)
/)